HDAC11 and prostate cancer: Moreover, prior research noted that HDAC11 was a novel prognostic marker, affecting apoptosis and maintaining the metabolism and viability of cancer cells in prostate cancer, pancreatic cancer, ovarian and breast cancer.30, 31